Part 9/14:
Steele acknowledges that while epigenetic reprogramming holds promise, it doesn't address all aspects of aging—such as DNA mutations or extracellular tissue damage—which underscores the importance of a multifaceted approach.
Repurposing Existing Drugs for Longevity
In the short term, many promising interventions involve repurposing existing drugs with known safety profiles. For example:
- Metformin, a common diabetes medication, is currently under study to determine its potential to delay various age-related diseases, including cancer and dementia. Its trials aim to see if it can extend healthspan over a period of several years.